Comparison of dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of disease progression with dopamine transporter SPECT | Charles Explorer

Comparison of dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of disease progression with dopamine transporter SPECT

Publication

Abstract

Dihydroergocryptine, levodopa, Parkinson's disease

People